340binformed.org - Your Free Source for 340B News and Commentary

New Federal 340B Order Is Major Step Toward Restoring Drug Discounts

Print ArticleMay 19, 2021– The Health Resources & Services Administration (HRSA) has taken decisive action to put a stop to the actions of six drug companies that are denying 340B drug pricing program discounts for medications dispensed at community pharmacies. The action could lead to the end of a nearly year-long dispute pitting for-profit pharmaceutical […]

More States Acting To Protect 340B Safety-Net Hospitals

Print ArticleMay 12, 2021– Faced with increasing threats from some pharmaceutical benefit managers (PBMs) and drug companies, supporters of the 340B drug pricing program have turned to state governments for protection and are finding increasing support in the form of new protective laws thanks to the work of 340B advocates in the states. To date, […]

Americans Pay Far More for Drugs Than Other Countries

May 7, 2021– Americans are charged at least two to four times more for 20 major brand-name drugs, according to a new report to Congress. The Government Accountability Office (GAO) looked at the retail prices charged for brand-name, single-source … [Read More...]

Faces of 340B: Meeting the Mission of a Healthier Community

April 29, 2021 – At MetroHealth in Cleveland, the health providers and the staff who support them work as one to meet the health system’s mission of “leading the way to a healthier you and a healthier community.” One of the key elements that helps … [Read More...]

Undoing Medicare 340B Cuts Would Not Cost Patients or Taxpayers Anything

April 23, 2021– Billions of dollars in Medicare payment cuts to hospitals participating in the 340B drug pricing program have harmed the health care safety net since they first went into effect more than three years ago. 340B hospitals and their … [Read More...]

Research Highlights the Toll of Drug Maker Attacks on 340B, Shows How Hospitals Use Their Savings to Care for Patients

March 23, 2021– Newly released research demonstrates how patients benefit from the 340B drug pricing program in the form of expanded access and improved health outcomes. But there is growing evidence that the actions of six drug companies to cut off … [Read More...]

New Data May Convince Congress To Close 340B Loophole

March 18, 2021– One of the quieter debates around the 340B drug pricing program is percolating on Capitol Hill as lawmakers consider whether to plug a loophole in the law that costs rural hospitals much-needed resources. Members of Congress from both … [Read More...]

340B Providers Contemplate the Challenges Met and Prepare for the Ones Ahead

By Maureen Testoni March 11, 2021– In this pandemic-focused world we all find ourselves in, it seems only fitting that one of my highlights of this past month was getting the chance to meet Fauci. No, I’m not talking about the esteemed Dr. … [Read More...]

The Human Toll of Drug Company Restrictions on 340B